Aromatase Inhibitors for treatment of metastatic breast cancer

  • Protocol
  • Intervention

Authors

  • J Bliss,

  • L Gibson


Ms Judith Bliss, Head, Clinical Trials and Statistics Unit, The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey, UK. j.bliss@icr.ac.uk.

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

This systematic review aims to assess the efficacy of aromatase inhibitors in the treatment of metastatic breast cancer.